Company / Income Tax
Esperion Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.8M
FY2025
5-year range
$0 / $1.8M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#66 of 204
Health Care
What the data says
At $2M, Esperion Therapeutics, Inc.'s income tax ranks #139 of 204 in the Health Care sector. Increased from $0 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025.
Increased from $0 to $2M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#139 of 204 in Health CareTop 68% of 204This company $1.8M Sector average $118.7M
▼
-98.4% below sector average
Key checks
Key Insights
- Ranks #66 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8M | - |
| FY2024 | $0 | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026